PharmswellBio Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,576
6,694
8,566
4,579
10,499
Total Accounts Receivable
7,355
8,037
11,353
8,383
11,223
Inventories
1,887
1,552
1,103
1,408
1,929
Other Current Assets
87
672
71
788
181
Total Current Assets
11,905
16,955
21,093
15,159
23,833
Net Property, Plant & Equipment
6,520
205
181
303
222
Total Investments and Advances
474
3,411
436
2,896
2,226
Long-Term Note Receivable
39
41
43
45
44
Intangible Assets
1,384
1,632
1,190
726
635
Other Assets
5
-
-
514
2,074
Total Assets
20,327
22,245
22,943
19,643
29,035
ST Debt & Current Portion LT Debt
7,293
6,935
10,613
6,540
7,896
Accounts Payable
2,247
2,655
1,846
1,560
2,046
Other Current Liabilities
739
775
1,768
1,646
1,673
Total Current Liabilities
10,279
10,365
14,227
9,746
11,615
Long-Term Debt
-
3,163
-
-
-
Provision for Risks & Charges
83
105
109
86
164
Deferred Taxes
582
-
-
-
-
Total Liabilities
10,944
13,633
14,337
9,832
11,779
Common Equity (Total)
9,541
8,772
8,606
9,811
17,256
Total Shareholders' Equity
9,541
8,772
8,606
9,811
17,256
Total Equity
9,383
8,612
8,606
9,811
17,256
Liabilities & Shareholders' Equity
20,327
22,245
22,943
19,643
29,035
Accumulated Minority Interest
159
160
-
-
-

About PharmswellBio Co.

View Profile
Address
High Heels Building
Seoul SL 08514
Korea, Republic Of
Employees -
Website -
Updated 09/14/2018
PharmswellBio Co., Ltd. engages in the development, manufacture, and distribution of pharmaceutical raw materials. It operates through following business divisions: Active Pharmaceutical Ingredient and Other. Its products include synthesis material drugs, healthcare foods, and bio-pharmaceuticals.